| OCUP Shares Outstanding History Table | ||||||||||||||||||||||||||||||
Below is a table of the OCUP shares outstanding history going back to 11/6/2020:
Also see: OCUP Market Cap History OCUP YTD Return |
OCUP Shares Outstanding History — Ocuphire Pharma Share Count Over Time
As of 8/9/2024 Ocuphire Pharma has 26.20 million OCUP shares outstanding. Investors often track the OCUP shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows OCUP share count trends over time, with 14 historical shares outstanding datapoints presented, dating back to 11/6/2020.
| OCUP Shares Outstanding History Chart | |||||||||||||||||||||||||||||||
OCUP Historical Shares Outstanding: +131.42% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||
| OCUP Stock Price Chart |
| About Opus Genetics Inc |
| Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Co.'s primary product candidate, Nyxol® Eye Drops, is a once-daily eye drop formulation of phentolamine mesylate designed to reduce pupil diameter and improve visual acuity. Co.'s second product candidate, APX3330, is a twice-a-day oral tablet designed to target multiple pathways relevant to retinal and choroidal (the vascular layer of the eye) diseases such as diabetic retinopathy and diabetic macular edema which, if left untreated, can result in permanent visual acuity loss and eventual blindness. We show 14 historical shares outstanding datapoints in our coverage of OCUP's shares outstanding history. Understanding the changing numbers of OCUP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like OCUP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching OCUP by allowing them to research OCUP shares outstanding history as well as any other stock in our coverage universe. |
| OCUP Current Stock Quote |
Quotes delayed 20 minutes  Free OCUP Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| OCUP Share Performance |
| Shares Outstanding Peers |
| Ocuphire Pharma (OCUP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
OCX Shares Outstanding History ODT Shares Outstanding History ODYS Shares Outstanding History OFIX Shares Outstanding History OGN Shares Outstanding History OHRP Shares Outstanding History OKUR Shares Outstanding History OLMA Shares Outstanding History OM Shares Outstanding History OMED Shares Outstanding History More Healthcare companies » |
OCUP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
